SYROS PHARMACEUTICALS INC's ticker is SYRS and the CUSIP is 87184Q107. A total of 77 filers reported holding SYROS PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 1.60 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $339,000 | -23.6% | 75,904 | -6.8% | 0.00% | -25.0% |
| Q2 2021 | $444,000 | -46.8% | 81,474 | -26.9% | 0.00% | -50.0% |
| Q1 2021 | $834,000 | -7.0% | 111,510 | +34.8% | 0.01% | -20.0% |
| Q4 2020 | $897,000 | +73.8% | 82,714 | +41.7% | 0.01% | +25.0% |
| Q3 2020 | $516,000 | -22.3% | 58,358 | -6.4% | 0.01% | -11.1% |
| Q2 2020 | $664,000 | -10.6% | 62,327 | -23.3% | 0.01% | +80.0% |
| Q1 2019 | $743,000 | +71.6% | 81,287 | +4.5% | 0.01% | +66.7% |
| Q4 2018 | $433,000 | -38.9% | 77,768 | +30.6% | 0.00% | -40.0% |
| Q3 2018 | $709,000 | +46.8% | 59,553 | +26.0% | 0.01% | +66.7% |
| Q2 2018 | $483,000 | – | 47,273 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 881,450 | $5,677,000 | 1.32% |
| IFP Advisors, Inc | 50 | $1,000 | 0.00% |
| Ten Capital Wealth Advisors, LLC | 219 | $1,000 | 0.00% |